HPA dysregulation in patients with MDD is evident in enlarged adrenal glands [17,18], blunted adrenocorticotropic hormone (ACTH) response in corticotropin-releasing-hormone (CRH) tests [19] and elevated ACTH response in DEX-CRH tests [20,21]. This evidence concerns the gene CRH and major depressive disorder.